Back
Structure Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
GPCR
Structure Therapeutics
Last Price:
$25.90
Seasonality Move:
18.95%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Structure Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.52 | Buy |
| 20-day SMA: | 19.17 | Buy |
| 50-day SMA: | 20.59 | Buy |
| 200-day SMA: | 31.42 | Sell |
| 8-day EMA: | 23.15 | Buy |
| 20-day EMA: | 21.13 | Buy |
| 50-day EMA: | 21.6 | Buy |
| 200-day EMA: | 29.19 | Sell |
Structure Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.27 | Buy |
| Relative Strength Index (14 RSI): | 71.39 | Buy |
| Chaikin Money Flow: | 949882 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.77 - 22.69) | Buy |
| Bollinger Bands (100): | (19.71 - 29.67) | Buy |
Structure Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics Stock
Is Structure Therapeutics Stock a Buy?
-
Structure Therapeutics share price is 25.91 while GPCR 8-day simple moving average is 23.52, which is a Buy signal.
-
The stock price of GPCR is 25.91 while Structure Therapeutics 20-day SMA is 19.17, which makes it a Buy.
-
Structure Therapeutics 50-day simple moving average is 20.59 while GPCR share price is 25.91, making it a Buy technically.
-
GPCR stock price is 25.91 and Structure Therapeutics 200-day simple moving average is 31.42, creating a Sell signal.
GPCR Technical Analysis vs Fundamental Analysis
Sell
50
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy or a Sell?
-
Structure Therapeutics stock is rated a SellThe current Structure Therapeutics [GPCR] share price is $25.91. The Score for GPCR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Structure Therapeutics Stock Info
Market Cap:
1.5B
Price in USD:
25.91
Share Volume:
1.4M
Structure Therapeutics 52-Week Range
52-Week High:
62.74
52-Week Low:
13.22
Sell
50
Structure Therapeutics (GPCR)
is a Sell
Structure Therapeutics Share Price Forecast
-
What is the Structure Therapeutics stock price today?The Structure Therapeutics stock price is 25.91 USD today.
-
Will GPCR stock go up or go down?Structure Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Structure Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics is overvalued.
Is Structure Therapeutics Stock a Buy?
-
Structure Therapeutics share price is 25.91 while GPCR 8-day exponential moving average is 23.15, which is a Buy signal.
-
The stock price of GPCR is 25.91 while Structure Therapeutics 20-day EMA is 21.13, which makes it a Buy.
-
Structure Therapeutics 50-day exponential moving average is 21.60 while GPCR share price is 25.91, making it a Buy technically.
-
GPCR stock price is 25.91 and Structure Therapeutics 200-day simple moving average is 29.19, creating a Sell signal.
Fundamental Analysis of Structure Therapeutics
Is Structure Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.08 per share, and a decrease next year of $0.68 per share.
Technical Analysis of Structure Therapeutics
Should I short Structure Therapeutics stock?
-
GPCR Moving Average Covergence Divergence (MACD) indicator is 1.27, suggesting Structure Therapeutics is a Buy
-
Structure Therapeutics Relative Strength Index (RSI) is 71.39, which suggest Structure Therapeutics is overbought
-
The Bollinger Bands (25) for Structure Therapeutics is (15.77 - 22.69), which suggest Structure Therapeutics is a Buy
-
The Bollinger Bands (100) for Structure Therapeutics is (19.71 - 29.67), which suggest Structure Therapeutics is a Buy
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.